CN107905027A - Paper for daily use with bacteria resistance function - Google Patents
Paper for daily use with bacteria resistance function Download PDFInfo
- Publication number
- CN107905027A CN107905027A CN201711393894.5A CN201711393894A CN107905027A CN 107905027 A CN107905027 A CN 107905027A CN 201711393894 A CN201711393894 A CN 201711393894A CN 107905027 A CN107905027 A CN 107905027A
- Authority
- CN
- China
- Prior art keywords
- paper
- daily use
- component
- resistance function
- bacteria resistance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 23
- 241000196324 Embryophyta Species 0.000 claims abstract description 41
- 241000984231 Atractylodes chinensis Species 0.000 claims abstract description 20
- 229930101531 artemisinin Natural products 0.000 claims abstract description 19
- 229960004191 artemisinin Drugs 0.000 claims abstract description 18
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 claims abstract description 18
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 claims abstract description 15
- 229940119569 wormwood extract Drugs 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 30
- 229940079593 drug Drugs 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 14
- 230000000844 anti-bacterial effect Effects 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims 1
- 230000001408 fungistatic effect Effects 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 description 27
- 240000006891 Artemisia vulgaris Species 0.000 description 20
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 19
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 18
- 235000003097 Artemisia absinthium Nutrition 0.000 description 18
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 18
- 239000001138 artemisia absinthium Substances 0.000 description 18
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 16
- 235000001405 Artemisia annua Nutrition 0.000 description 15
- 240000000011 Artemisia annua Species 0.000 description 15
- 238000005516 engineering process Methods 0.000 description 14
- 239000012895 dilution Substances 0.000 description 11
- 238000010790 dilution Methods 0.000 description 11
- 239000000654 additive Substances 0.000 description 10
- 230000000996 additive effect Effects 0.000 description 10
- 238000004806 packaging method and process Methods 0.000 description 10
- 238000005507 spraying Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 235000010894 Artemisia argyi Nutrition 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 244000030166 artemisia Species 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 241001480043 Arthrodermataceae Species 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000192041 Micrococcus Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000015604 Artemisia caruifolia Nutrition 0.000 description 1
- 241000615735 Artemisia carvifolia Species 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 241001252601 Blumea Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000007591 painting process Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- ZISJLHQNEVGTIU-RFEYTNPVSA-M sodium 4-oxo-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxy]butanoate Chemical compound [Na+].C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC([O-])=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4 ZISJLHQNEVGTIU-RFEYTNPVSA-M 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
- D21H17/02—Material of vegetable origin
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47K—SANITARY EQUIPMENT NOT OTHERWISE PROVIDED FOR; TOILET ACCESSORIES
- A47K10/00—Body-drying implements; Toilet paper; Holders therefor
- A47K10/16—Paper towels; Toilet paper; Holders therefor
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
- D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
- D21H21/36—Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicines Containing Plant Substances (AREA)
- Paper (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a kind of paper for daily use with bacteria resistance function, it is related to paper for daily use technical field, include the plant bacteriostasis efficacy component that weight ratio is 0.01%~2.0% in its paper for daily use, the bacteriostasis efficacy component is wormwood extract, atractylodes chinensis, Artemisinin, compared with prior art, the hand after clear water is washed is wiped using the paper for daily use of the present invention, with obvious fungistatic effect, at the same time also have do not stimulate skin, it is safe and reliable, it is easy to carry the characteristics of.
Description
Technical field
It is especially a kind of to can be used for antibacterial paper for daily use the present invention relates to paper for daily use technical field.
Background technology
Paper for daily use product are the important composition component of personal-care supplies, closely bound up with people's lives.At present, Ren Menchang
Paper for daily use is mainly draw-out tissue, tissue, napkin paper, moisture paper tissue papers, toilet paper etc., its basic function is exactly clean surface
Each position of the body surfaces such as portion, hand, safeguards personal hygiene and health.With the improvement of living standards, the health care consciousness of consumer is not
Disconnected enhancing, it is also proposed paper for daily use the requirement of higher, requirement of the people to paper for daily use is except basic with this is cleaned
Some other functions is also add outside function, such as to paper for daily use perfuming, these simply simple, single fragrance of a flower, Wu Faman
Sufficient consumer demand.
The problems such as with environmental pollution, ecological disturbance, increasingly shows, and consumer increasingly closes the security of product
Note, also increasingly advocates natural and safe product.And add with the obvious natural Chinese medicinal herb for removing body surface harmful bacteria effect
The paper for daily use of extract, not only has the function that to protect health, but also has safety concurrently, it is green, portable the features such as, must
Consumption fashion and hot spot will be become.In addition, with the development of modernization of Chinese medicine technology, the side utilized to Chinese medicine study of active components
Method has also obtained fine development, this, which makes a living, applies flexibly paper product using active ingredient of Chinese herbs to aid in removal body surface pathogenic bacteria to provide
Good technical support.
Microorganism of the human body surface there is number in terms of million, the skin surface ecological balance of keeping fit are of great significance.
And body surface moment and external contact, air, body surface can destroy human body surface all there are a variety of etiologies after being contacted with not table
Microecological balance, causes pruitus, redness, and the easily invasion of direct oral cavity, hair follicle, the surface of a wound is internal, so as to cause inflammation, even
Trigger a variety of diseases.
Bacterium is main etiology.Consumer is mainly by keeping body surface to clean at present, using containing antibacterial anti-inflammatory
The products such as the facial cleanser of component, hand cleanser, although there is certain effect, there are it is inconvenient to carry the problems such as, it is big using limitation.Mesh
Preceding domestic with paper market still without a paper for daily use product with bacteriostasis, for this reason, it is necessary to comply with market development
Needs, developed a kind of dedicated for removing body surface pathogenic bacteria, safeguarded using safely and effectively Chinese medical extract as active ingredient
Microecological balance, protects the paper for daily use product of health.
The content of the invention
Problem to be solved by this invention is to provide a kind of paper for daily use for having bacteria resistance function and being convenient for carrying.
In order to solve the above-mentioned technical problem, the technical solution adopted in the present invention is:
Include the plant bacteriostasis efficacy component that weight ratio is 0.01%~2.0% in its paper for daily use, which is
Wormwood extract, atractylodes chinensis, Artemisinin.
In above-mentioned technical proposal, more specifically scheme can also be:In three kinds of plants bacteriostasis efficacy component, wormwood carries
It is 8 to take thing, atractylodes chinensis, the weight ratio of Artemisinin:1:1~1:1:8.
Further:In three kinds of plants bacteriostasis efficacy component, wormwood extract, atractylodes chinensis, Artemisinin
Weight ratio be 7:2:1~2:2:6.
Further:In three kinds of plants bacteriostasis efficacy component, wormwood extract, atractylodes chinensis, Artemisinin
Weight ratio be 6:3:1~3:3:4.
Further:The extracting method of plant bacteriostasis efficacy component is heating reflux method, using ethanol as solvent, is concentrated under reduced pressure
To extract:Crude drug=1:1, the bacteriostasis efficacy component need to be diluted when on the paper for daily use with solvent, dilution times
Number is 20~50 times, and retarder thinner is pure water or ethanol.
Further:The paper for daily use is draw-out tissue or tissue or napkin paper or moisture paper tissue papers or toilet paper.
Wormwood of the present invention:Scientific name:Artemisia argyiH. L é v. & Vaniot, alias:Xiao Mao, ice
Platform, hold back grass, fragrant Chinese mugwort, Chinese mugwort, Ai Xiao, argy wormwood, argy wormwood, fluffy ligusticumic, the yellow grass ﹑ moxas of Chinese mugwort ﹑ moxibustion grass ﹑ doctor's grass ﹑ etc..Belong to perennial herb or
Slightly there is enhanced aroma into suffruticose, plant.《Chinese Pharmacopoeia》Think that wormwood has warming channel for arresting bleeding, cold dispelling hemostasis, eliminating cold to stop pain;
External application removing dampness to stop itchin.For spitting blood, bleeding from five sense organs or subcutaneous tissue, uterine bleeding, menorrhalgia, blood under threatened abortion, few abdomen crymodynia, through uncomfortable, uterus cold infertile of trembling with fear;
Control pruitus outside.Vinegar Chinese mugwort charcoal warming channel for arresting bleeding, for deficient cold type bleeding.Folium artemisiae argyi in vitro to bacillus anthracis, Alpha-hemolytic streptococcus,
It is B- Streptococcus hemolyticus, corynebacterium diphtheriae, bacillus pseudodiphthericus, lung diplococcoid, staphylococcus aureus, Staphylococcus citreus, white
10 kinds of gram-positive Aeromonas bacterias such as Se Pu Portugals coccus, hay bacillus all have antibacterial action.Blumea oil 4 × 10(-3)Concentration(Examination
Tube method), to Diplococcus pneumopniae, staphylococcus aureus, staphylococcus albus, alpha streptococcus, Escherichia coli, typhoid bacillus,
Paratyphosum Bacterium, shigella flexneri etc. have bacteriostasis.Belong to the medicinal material of integration of drinking and medicinal herbs, it is safe.
Rhizoma atractylodis of the present invention:Scientific name:Atractylodes Lancea (Thunb.) DC., composite family [WTBX is for many years
Raw herbaceous plant.Rhizoma atractylodis root-like stock is used as medicine, and has eliminating dampness, changes turbid, analgesic effect, and atractylodes chinensis, which has, eliminates drug resistance Fu Shi dysentery
The effect of bacillus R plasmids, can reduce the generation of bacterial drug resistance.A kind of and medicinal material of integration of drinking and medicinal herbs.
Sweet wormwood of the present invention:Scientific name:Artemisia carvifolia,Annual herb.For feverfew chrysanthemum
The dry aerial parts of wormwood artemisia.Micro-pungent sweet in flavor, gas are trembled with fear, nontoxic.Sweet wormwood decocting liquid is to staphylococcus epidermis, micrococcus catarrhalis, anthrax bar
Bacterium, corynebacterium diphtheriae have stronger bacteriostasis, also have to staphylococcus aureus, Pseudomonas aeruginosa, shigella dysenteriae, tuberculosis stalk bacterium etc.
Certain inhibitory action.Sweet wormwood volatile oil has bacteriostasis in 0.25% concentration, to all dermatophytes, right in 1% concentration
All dermatophytes have bactericidal effect.Sweet wormwood is known as the effect of resisiting influenza virus.Sodium artesunate is to golden grape, Fu Shi dysentery bars
Bacterium, Escherichia coli, micrococcus catarrhalis, A type and paratyphoid B stalk bacterium have certain antibacterial action.Sitosterol in sweet wormwood and
Stigmasterol also has antivirus action.
By adopting the above-described technical solution, the invention has the advantages that:
The hand after clear water is washed is wiped using the paper for daily use of the present invention, there is obvious fungistatic effect, while also with not stimulating
Skin, it is safe and reliable, it is easy to carry the characteristics of.
Embodiment:
Below in conjunction with specific embodiment, elaborate to the present invention, but the present invention is not limited to this:
Embodiment 1:The draw-out tissue of the component of bacteriostasis efficacy containing plant
Plant bacteriostasis efficacy component is prepared by following proportioning components:
Wormwood extract:Atractylodes chinensis:Artemisinin=6:3:1
Extracting method is:By weight, by 6 parts of wormwood crude drugs, 3 parts of rhizoma atractylodis crude drugs, 1 part of sweet wormwood crude drug, is broken into certain grain
Spend and be uniformly mixed, with the ethanol heating and refluxing extractions 3 of 3 times of amounts it is small when, extract altogether 3 times, then No. 3 extracting solutions merged, are adopted
Pressure reducing mode is taken to concentrate, the amount to final plant bacteriostasis efficacy component is equal to the crude drug amount of addition.
Above-mentioned draw-out tissue production technology is to increase spraying process again in conventional decimation paper production technology.Manufactured plant is pressed down
After bacterium functional component dilutes 20 times with pure water, it is added to the mode of atomizing spraying on body paper, additive amount is by the plant before dilution
Thing bacteriostasis efficacy component is calculated as 0.1%, is then cut by specification requirement, packaging is made.
Embodiment 2:The draw-out tissue of the component of bacteriostasis efficacy containing plant
Matched by following component and prepare plant bacteriostasis efficacy component:
Wormwood extract:Atractylodes chinensis:Artemisinin=7:2:1
Extracting method is:By weight, wormwood crude drug, rhizoma atractylodis crude drug, the sweet wormwood crude drug extracting method system as described in embodiment 1 respectively
Standby plant bacteriostasis efficacy component, then it is equal by 7 parts of wormwood extracts, 2 parts of atractylodes chinensis, the proportioning mixing of 1 part of Artemisinin
The even component of bacteriostasis efficacy containing plant to obtain the final product.
Above-mentioned draw-out tissue production technology is to increase painting process in conventional decimation paper production technology.Manufactured plant is antibacterial
After functional component dilutes 30 times with ethanol, it is uniformly applied to by roller on body paper, additive amount is pressed down as before dilution containing plant
Bacterium functional component is calculated as 0.05%, is then cut by specification requirement, and packaging is made.
Embodiment 3:The tissue of the component of bacteriostasis efficacy containing plant
Matched by following component and prepare plant bacteriostasis efficacy component:
Wormwood extract:Atractylodes chinensis:Artemisinin=2:2:6
Extracting method is:By weight, respectively by 2 parts of wormwood crude drugs, 2 parts of rhizoma atractylodis crude drugs, 6 parts of sweet wormwood crude drugs, by the institute of embodiment 1
State extracting method and prepare plant bacteriostasis efficacy component.
Above-mentioned tissue production technique, additive amount as described in embodiment 1 is calculated as by the plant bacteriostasis efficacy component before dilution
0.5%, then cut by specification requirement, packaging is made.
Embodiment 4:The napkin paper of the component of bacteriostasis efficacy containing plant
Matched by following component and prepare plant bacteriostasis efficacy component:
Wormwood extract:Atractylodes chinensis:Artemisinin=3:3:4
Extracting method is:By weight, wormwood crude drug, rhizoma atractylodis crude drug, the sweet wormwood crude drug extracting method system as described in embodiment 1 respectively
It is uniformly mixed into extract, then by 3 parts of wormwood extracts, 3 parts of atractylodes chinensis, the proportioning of 4 parts of Artemisinins up to plant
Bacteriostasis efficacy component.
Above-mentioned napkin paper production technique, additive amount as described in embodiment 2 is calculated as by the plant bacteriostasis efficacy component before dilution
1.0%, then cut by specification requirement, packaging is made.
Embodiment 5:The moisture paper tissue papers of the component of bacteriostasis efficacy containing plant
Matched by following component and prepare plant bacteriostasis efficacy component:
Wormwood extract:Atractylodes chinensis:Artemisinin=1:1:8
Extracting method is:Respectively by 1 part of wormwood crude drug, 1 part of rhizoma atractylodis crude drug, 8 parts of sweet wormwood crude drugs, the extraction side as described in embodiment 1
Method prepares plant bacteriostasis efficacy component.
Above-mentioned moisture paper tissue papers production technique as described in embodiment 1, diluent are ethanol, and extension rate is 50 times, and additive amount is pressed
Plant bacteriostasis efficacy component before dilution is calculated as 2.0%, is then cut by specification requirement, packaging is made.
Embodiment 6:The toilet paper of the component of bacteriostasis efficacy containing plant
Matched by following component and prepare plant bacteriostasis efficacy component:
Wormwood extract:Atractylodes chinensis:Artemisinin=8:1:1
Extracting method is:By weight, wormwood crude drug, rhizoma atractylodis crude drug, the sweet wormwood crude drug extracting method system as described in embodiment 1 respectively
It is equal into plant bacteriostasis efficacy component, then by 8 parts of wormwood extracts, 1 part of atractylodes chinensis, the proportioning mixing of 1 part of Artemisinin
Even plant bacteriostasis efficacy component to obtain the final product.
Above-mentioned toilet paper production technique, additive amount as described in embodiment 2 is calculated as by the plant bacteriostasis efficacy component before dilution
0.01%, then cut by specification requirement, packaging is made.
Embodiment 7:Draw-out tissue containing atractylodes chinensis
Extracting method is:By weight, rhizoma atractylodis crude drug is broken into certain granularity and be uniformly mixed, added with the ethanol of 3 times of amounts
When circumfluence distillation 3 is small, extracts altogether 3 times, then No. 3 extracting solutions are merged, take pressure reducing mode to concentrate, are extracted to final rhizoma atractylodis
The amount of thing is equal to the crude drug amount of addition.
Above-mentioned draw-out tissue production technology is to increase spraying process again in conventional decimation paper production technology.Manufactured rhizoma atractylodis are carried
After taking thing pure water to dilute 20 times, it is added to the mode of atomizing spraying on body paper, additive amount is by the rhizoma atractylodis extraction before dilution
Thing is calculated as 0.1%, is then cut by specification requirement, and packaging is made.
Embodiment 8:Draw-out tissue containing Artemisinin
Extracting method is:By weight, sweet wormwood crude drug is broken into certain granularity and be uniformly mixed, added with the ethanol of 3 times of amounts
When circumfluence distillation 3 is small, extracts altogether 3 times, then No. 3 extracting solutions are merged, take pressure reducing mode to concentrate, are extracted to final sweet wormwood
The amount of thing is equal to the crude drug amount of addition.
Above-mentioned draw-out tissue production technology is to increase spraying process again in conventional decimation paper production technology.Manufactured sweet wormwood is carried
After taking thing pure water to dilute 20 times, it is added to the mode of atomizing spraying on body paper, additive amount is by the sweet wormwood extraction before dilution
Thing is calculated as 0.1%, is then cut by specification requirement, and packaging is made.
Embodiment 9:Draw-out tissue containing wormwood extract
Extracting method is:By weight, wormwood crude drug is broken into certain granularity and be uniformly mixed, added with the ethanol of 3 times of amounts
When circumfluence distillation 3 is small, extracts altogether 3 times, then No. 3 extracting solutions are merged, take pressure reducing mode to concentrate, are extracted to final wormwood
The amount of thing is equal to the crude drug amount of addition.
Above-mentioned draw-out tissue production technology is to increase spraying process again in conventional decimation paper production technology.Manufactured wormwood is carried
After taking thing pure water to dilute 20 times, it is added to the mode of atomizing spraying on body paper, additive amount is by the wormwood extraction before dilution
Thing is calculated as 0.1%, is then cut by specification requirement, and packaging is made.
Above-mentioned draw-out tissue production technology is to increase spraying process again in conventional decimation paper production technology.By manufactured extract
After diluting 20 times with pure water, it is added to the mode of atomizing spraying on body paper, additive amount is calculated as by the extract before dilution
0.1%, then cut by specification requirement, packaging is made.
Clinical test part:
The method that this product takes consumer tests, randomly selects 240 testers, and men and women is fifty-fifty, is randomly divided into 8 groups, every group 30
People;Tester first detects total number of bacteria on hand, and it is using preceding average bacteriological sum to take each cell mean;Then all testers use
After clear water is washed one's hands, first group of draw-out tissue using embodiment 1 dries hand, and second group of draw-out tissue using embodiment 2 dries hand, the
Three groups of draw-out tissues using embodiment 7 dry hand, and the 4th group has used the draw-out tissue of embodiment 8 to dry hand, and the 5th group uses
The draw-out tissue of embodiment 9 dries hand, and the 6th group, the 7th group and the 8th group respectively with common draw-out tissue, dry towel, drier
Hand, then detects the instant bacterium residual amount of each group tester's hand, is averaged, and the bacterial number after 30 minutes,
It is averaged.
As a result it is as follows:(Unit:cfu/cm2)
The result shows that the paper for daily use product bacterium residual that with the addition of the Chinese medical extract is minimum, bacterial number in 30 minutes defensive positions
At least, and there is a significant difference.
Claims (7)
- A kind of 1. paper for daily use with bacteria resistance function, it is characterised in that:Include in its paper for daily use weight ratio for 0.01%~ 2.0% plant bacteriostasis efficacy component, which is wormwood extract, atractylodes chinensis, Artemisinin.
- 2. the paper for daily use according to claim 1 with bacteria resistance function, it is characterised in that:The antibacterial work(of three kinds of plants Imitate in component, wormwood extract, atractylodes chinensis, the weight ratio of Artemisinin are 8:1:1~1:1:8.
- 3. the paper for daily use according to claim 1 with bacteria resistance function, it is characterised in that:The antibacterial work(of three kinds of plants Imitate in component, wormwood extract, atractylodes chinensis, the weight ratio of Artemisinin are 7:2:1~2:2:6.
- 4. the paper for daily use according to claim 1 with bacteria resistance function, it is characterised in that:The antibacterial work(of three kinds of plants Imitate in component, wormwood extract, atractylodes chinensis, the weight ratio of Artemisinin are 6:3:1~3:3:4.
- 5. according to the paper for daily use with bacteria resistance function described in claim 1 or 2 or 3 or 4, it is characterised in that:The antibacterial work(of plant The extracting method for imitating component is heating reflux method, using ethanol as solvent, is concentrated under reduced pressure into extract:Crude drug=1:1, it is described antibacterial Functional component need to be diluted when on the paper for daily use with solvent, and extension rate is 20~50 times, and retarder thinner is pure Water purification or ethanol.
- 6. according to the paper for daily use with bacteria resistance function described in claim 1 or 2 or 3 or 4, it is characterised in that:The life is used Paper is draw-out tissue or tissue or napkin paper or moisture paper tissue papers or toilet paper.
- 7. according to the paper for daily use with bacteria resistance function described in claim 5, it is characterised in that:The paper for daily use is draw-out tissue Or tissue or napkin paper or moisture paper tissue papers or toilet paper.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711393894.5A CN107905027A (en) | 2017-12-21 | 2017-12-21 | Paper for daily use with bacteria resistance function |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711393894.5A CN107905027A (en) | 2017-12-21 | 2017-12-21 | Paper for daily use with bacteria resistance function |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107905027A true CN107905027A (en) | 2018-04-13 |
Family
ID=61870704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711393894.5A Pending CN107905027A (en) | 2017-12-21 | 2017-12-21 | Paper for daily use with bacteria resistance function |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107905027A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108815224A (en) * | 2018-06-22 | 2018-11-16 | 贵州龙源冷水渔业有限公司 | A kind of sturgeon germ inhibitor |
CN110754686A (en) * | 2019-11-12 | 2020-02-07 | 广东中烟工业有限责任公司 | Faint scent type cigarette and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102961779A (en) * | 2012-12-04 | 2013-03-13 | 深圳市宜丽环保科技有限公司 | Sanitary towel core plate with plant bacteriostatic and odor removing functions |
CN104490674A (en) * | 2014-12-08 | 2015-04-08 | 成都顺发消洗科技有限公司 | Disinfectant wet wipe |
CN104523477A (en) * | 2014-12-08 | 2015-04-22 | 成都顺发消洗科技有限公司 | Preparation method for disinfecting wet wipe |
CN106344461A (en) * | 2016-10-28 | 2017-01-25 | 皖南医学院 | Multifunctional environment-friendly infant wet tissue and preparation method thereof |
-
2017
- 2017-12-21 CN CN201711393894.5A patent/CN107905027A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102961779A (en) * | 2012-12-04 | 2013-03-13 | 深圳市宜丽环保科技有限公司 | Sanitary towel core plate with plant bacteriostatic and odor removing functions |
CN104490674A (en) * | 2014-12-08 | 2015-04-08 | 成都顺发消洗科技有限公司 | Disinfectant wet wipe |
CN104523477A (en) * | 2014-12-08 | 2015-04-22 | 成都顺发消洗科技有限公司 | Preparation method for disinfecting wet wipe |
CN106344461A (en) * | 2016-10-28 | 2017-01-25 | 皖南医学院 | Multifunctional environment-friendly infant wet tissue and preparation method thereof |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108815224A (en) * | 2018-06-22 | 2018-11-16 | 贵州龙源冷水渔业有限公司 | A kind of sturgeon germ inhibitor |
CN110754686A (en) * | 2019-11-12 | 2020-02-07 | 广东中烟工业有限责任公司 | Faint scent type cigarette and preparation method thereof |
CN110754686B (en) * | 2019-11-12 | 2022-03-22 | 广东中烟工业有限责任公司 | Faint scent type cigarette and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101864409B1 (en) | Antibacterial or antifungal composition comprising oriental medicine extract and microbial ferment extract as an active ingredient | |
CN101129322A (en) | Multiple-effect bathing powder for nursing skin, method of manufacturing and method of using the same | |
CN101181208B (en) | Gargle containing natural antibiotics and preparation method thereof | |
CN107905027A (en) | Paper for daily use with bacteria resistance function | |
CN113616774B (en) | Antibacterial composition containing plant stem cells, maintenance antibacterial liquid and preparation method thereof | |
CN101658665A (en) | Formula of medicated bath | |
CN100593974C (en) | Achillea alpina tea | |
CN114712482A (en) | Vagina-cleaning bacteriostatic gel containing astaxanthin and preparation method thereof | |
CN105832619A (en) | Sterilization and deodorization foot bath salt and preparation method | |
CN103656397A (en) | Compound medicine for treating chronic pharyngitis | |
CN109481724A (en) | A kind of antibacterial warms up palace and dispels peculiar smell super-absorbent sanitary napkin and preparation method thereof | |
CN104288552A (en) | Vagina-cleaning care solution and preparation method thereof | |
CN103372087A (en) | Skin protecting health-care traditional Chinese medicine composition | |
CN106902070A (en) | Gentle plant essence hand lotion | |
CN111481567A (en) | Compound ozone oil and preparation method and application thereof | |
CN102526694A (en) | Lotion beneficial to health of anus and preparation method thereof | |
CN110974935A (en) | Antibacterial nursing gel containing fullerene C60 component and preparation method thereof | |
CN107184492B (en) | Health-care toothpaste and preparation method thereof | |
CN104689292A (en) | Compound essential oil with refreshing effect and sterilization and disinfection effect | |
CN105107014B (en) | A kind of medical bio skin antiallergic dressing and preparation method thereof | |
CN105534373B (en) | It is a kind of with antibacterial, disinfection towel and preparation method thereof of going to the lavatory | |
WO2020078051A1 (en) | Skin care agent containing 4-terpineol and preparation method therefor | |
CN106798701A (en) | A kind of Chinese medicine bath cream for preventing and treating pruitus and preparation method thereof | |
CN106265457A (en) | A kind of Weight-reducing health essence and preparation method | |
CN104511046A (en) | Women's menstrual antibacterial nursing pad prepared from water lily extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180413 |
|
RJ01 | Rejection of invention patent application after publication |